Skip to content

Author

A. Bellemain-Appaix

We have 2 of 110 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Lipid risk profile in ACS in young women: contribution of Lp(a) measurement: ancillary analysis of the WAMIF study

Young women presenting with acute coronary syndrome (ACS) represent a distinct clinical phenotype with heterogeneous mechanisms: premature atherosclerosis and non-obstructive coronary disease. In the WAMIF study (Women with Acute Myocardial Infarction), a French national multicenter cohort of women under 50 years...

S. Manzo-Silberman, A. Bellemain-Appaix, R. Khani-Bittar et al. · 0 citations
Open access Aug 2026

LDL Cholesterol Lowering With Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction: The AMUNDSEN Randomized Clinical Trial.

In patients with acute MI undergoing PCI, first-line evolocumab combined with high-intensity lipid-lowering therapy produced rapid and sustained LDL-C reduction, with more than 80% of patients reaching the guideline-recommended target at 1 year.

G. Montalescot, E. Ferrari, G. Souteyrand et al. · 3 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.